GENECAST
PrivateLast Round
IPO
Jun 28, 2024
Est. Valuation
$39.71M
Total Funding Raised
$21.29M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
GENECAST is a biotechnology company that develops cancer diagnostic technology equipment designed to detect, diagnose, and treat early-stage cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GENECAST Comparables
Compare GENECAST with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Biofidelity | 80% | |
| Gencurix Inc | 78% | |
| DiaCarta, Inc. | 77% |
GENECAST Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | Jun 28, 2024 | ||||
| Strategic | Feb 23, 2023 | ||||
| Series B | Jun 8, 2020 | ||||
| Series A | May 8, 2018 | ||||
| Seed | Oct 1, 2017 |
GENECAST Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KOTEC | Series A |
| KDB Capital Corp | Series B |
| SparkLabs Group | Seed |
| Winvest Venture Capital | Series B, IPO |
| IBK Capital | Series A |
| CJ Investment | Series B, Series A |
| KB Securities | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Monthly visitors increased 89% MoM to 4.9K.
- Jun 28, 2024
Raised $4M with Suseong Asset Management and Winvest Venture Capital.
GENECAST Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about GENECAST's valuation, stock price, and market status.
Is GENECAST a public or private company?
GENECAST is a private company.
What is the current stock price of GENECAST?
GENECAST is a private company with no public stock price. No recent secondary market data is available.
How much is GENECAST worth (valuation)?
GENECAST's valuation is estimated at $43.9M based on funding round data.
Can I buy GENECAST stock?
GENECAST shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was GENECAST's last funding round?
GENECAST's most recent funding round was Private Equity on June 28, 2024.
Who are the main investors in GENECAST?
Key investors in GENECAST include Partners Investment.
Will GENECAST IPO soon?
No public IPO plans have been announced for GENECAST.
How can I track GENECAST secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor GENECAST's secondary market activity and sign up for updates.